Entity Details
| Primary name |
SC5A2_HUMAN |
| Entity type |
UniProt |
| Source |
Source Link |
Details
| Accession | P31639 |
| EntryName | SC5A2_HUMAN |
| FullName | Sodium/glucose cotransporter 2 |
| TaxID | 9606 |
| Evidence | evidence at transcript level |
| Length | 672 |
| SequenceStatus | complete |
| DateCreated | 1993-07-01 |
| DateModified | 2021-06-02 |
Subcellular Location
Show/Hide Table
| Subcellular Location |
| Membrane |
Domains
Show/Hide Table
| Domain | Name | Category | Type |
| IPR001734 | Sodium/solute symporter | Family | Family |
| IPR018212 | Sodium/solute symporter, conserved site | Site | Conserved site |
| IPR038377 | Sodium/glucose symporter superfamily | Family | Homologous superfamily |
Diseases
Show/Hide Table
| Disease ID | Source | Name | Description |
| 233100 | OMIM | Renal glucosuria (GLYS) | A disorder characterized by persistent isolated glucosuria, normal fasting serum glucose concentration, decreased renal tubular resorption of glucose from the urine, and absence of any other signs of tubular dysfunction. The disease is caused by variants affecting the gene represented in this entry. |
Drugs
Show/Hide Table
| Drug | Name | Source | Type |
| DB01914 | D-glucose | Swissprot | small molecule |
| DB06292 | Dapagliflozin | Drugbank | small molecule |
| DB08907 | Canagliflozin | Drugbank | small molecule |
| DB09038 | Empagliflozin | Drugbank | small molecule |
| DB11827 | Ertugliflozin | Drugbank | small molecule |
Interactions
1 interaction